The combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy did not help patients with metastatic ...

Although exposure to ultraviolet rays is a primary cause of skin cancer, factors such as your age, sex, and smoking habits also may contribute to developing this health issue.

New research published in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, ...

Regeneron Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its blockbuster cancer drug Libtayo for certain ...

Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence ...

Regeneron (REGN) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion for ...

Kidman Park man, Joshua Giorgio died surrounded by family and friends on October 4 this year after a brave battle with oral ...

A new deep learning tool accurately predicts metastatic risk in cSCC, outperforming current clinicopathological and molecular ...

What started as a routine dental infection for Kempton Park resident Jaco Pretorius turned into a life-altering squamous cell carcinoma diagnosis.

The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...

Could a daily vitamin B3 pill prevent skin cancer? New research finds nicotinamide cuts recurrence risk by more than half in ...

The company is studying the mRNA tumor-associated antigen vaccine as a monotherapy and in combination with Keytruda.